Vertex, U.K. reach reimbursement deal for CRISPR-based medicine for sickle cell disease U.K. officials had originally raised concerns about the durability of the one-time medicine’s benefits

https://www.statnews.com/2025/01/30/uk-casgevy-vertex-nice-sickle-cell-reimbursement/